TransCode Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $392.00 on 04/05/23, and the lowest price during the same period was recorded at $0.56 on 02/06/24.
52-week price history of RNAZ Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. TransCode Therapeutics Inc’s current trading price is -99.83% away from its 52-week high, while its distance from the 52-week low is 21.96%. The stock’s price range for this period has remained between $0.56 and $392.00. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.25 million for the day, which was noticeably lower compared to the shares’ average daily volume of 0.65 million over the last three months.
Financial Performance and Market Capitalization
TransCode Therapeutics Inc (RNAZ) has experienced a quarterly decline of -90.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.49M and boasts a workforce of 19 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.6038, with a change in price of -13.9210. Similarly, TransCode Therapeutics Inc recorded 428,204 in trading volume during the last 100 days, posting a change of -95.32%.
RNAZ Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RNAZ stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.04.
RNAZ Stock Stochastic Average
As of today, the raw stochastic average of TransCode Therapeutics Inc over the last 50 days is at 6.28%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 65.66%. Further, the company’s Stochastic %K and %D values for the last 20 days were 60.20% and 58.53%, respectively.
RNAZ Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a loss of -89.64%.However, over the last six months, we can see a stronger performance of -97.10%. Over the last 30 days, the price of RNAZ has leaped by -2.64%. And in the last five days, it has surged by 0.15%.
